Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma

Clinical trial NCT01774344 · COMPLETED

Trial details

NCT number: NCT01774344
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2013-05-14
Primary completion: 2016-02-29
Enrollment: 573

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.